These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 28282719)

  • 1. Pharmacogenetics and Personalized Medicine in Pancreatic Cancer.
    Hosseini Bereshneh A; Morshedi F; Hematyar M; Kaki A; Garshasbi M
    Acta Med Iran; 2017 Mar; 55(3):194-199. PubMed ID: 28282719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Well-differentiated pancreatic neuroendocrine tumors: from genetics to therapy.
    de Wilde RF; Edil BH; Hruban RH; Maitra A
    Nat Rev Gastroenterol Hepatol; 2012 Feb; 9(4):199-208. PubMed ID: 22310917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic profiling guides the choice of molecular targeted therapy of pancreatic cancer.
    Frank TS; Sun X; Zhang Y; Yang J; Fisher WE; Gingras MC; Li M
    Cancer Lett; 2015 Jul; 363(1):1-6. PubMed ID: 25890222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenomics update in pancreatic cancer.
    Puri A; Saif MW
    JOP; 2014 Mar; 15(2):114-7. PubMed ID: 24618431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toward the goal of personalized therapy in pancreatic cancer by targeting the molecular phenotype.
    Yee NS
    Adv Exp Med Biol; 2013; 779():91-143. PubMed ID: 23288637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic and molecular alterations in pancreatic cancer: implications for personalized medicine.
    Fang Y; Yao Q; Chen Z; Xiang J; William FE; Gibbs RA; Chen C
    Med Sci Monit; 2013 Oct; 19():916-26. PubMed ID: 24172537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Personalized Medicine and Nonmotor Symptoms in Parkinson's Disease.
    Titova N; Chaudhuri KR
    Int Rev Neurobiol; 2017; 134():1257-1281. PubMed ID: 28805572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Speeding towards individualized treatment for pancreatic cancer by taking an alternative road.
    Iovanna J; Dusetti N
    Cancer Lett; 2017 Dec; 410():63-67. PubMed ID: 28947138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds.
    Catts ZA; Baig MK; Milewski B; Keywan C; Guarino M; Petrelli N
    Ann Surg Oncol; 2016 May; 23(5):1729-35. PubMed ID: 26727920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenetics of osteoporosis: towards novel theranostics for personalized medicine?
    Rojo Venegas K; Aguilera Gómez M; Cañada Garre M; Sánchez AG; Contreras-Ortega C; Calleja Hernández MA
    OMICS; 2012 Dec; 16(12):638-51. PubMed ID: 23215803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic cancer: challenges and opportunities.
    Zhu H; Li T; Du Y; Li M
    BMC Med; 2018 Nov; 16(1):214. PubMed ID: 30463539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Factors as a Component of the Personalized Treatment Approach to Advanced Pancreatic Cancer: a Systematic Literature Review.
    Skelton WP; Parekh H; Starr JS; Trevino J; Cioffi J; Hughes S; George TJ
    J Gastrointest Cancer; 2018 Mar; 49(1):1-8. PubMed ID: 29110227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Progress in the personalized medicine using pharmacometabonomics].
    Huang Q; A JY; Zhou GH
    Yao Xue Xue Bao; 2014 Nov; 49(11):1491-7. PubMed ID: 25757272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endoscopic ultrasound-guided fine-needle aspirate-derived preclinical pancreatic cancer models reveal panitumumab sensitivity in KRAS wild-type tumors.
    Berry W; Algar E; Kumar B; Desmond C; Swan M; Jenkins BJ; Croagh D
    Int J Cancer; 2017 May; 140(10):2331-2343. PubMed ID: 28198009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarkers for personalized medicine in GI cancers.
    Zhang SY; Zhang SQ; Nagaraju GP; El-Rayes BF
    Mol Aspects Med; 2015 Nov; 45():14-27. PubMed ID: 26054566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A Novel Treatment Strategy for Pancreatic Cancer Based on Gene Profiles].
    Hayashi H; Nishihara H
    Gan To Kagaku Ryoho; 2016 Nov; 43(11):1326-1331. PubMed ID: 27899773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for the importance of personalized molecular profiling in pancreatic cancer.
    Lili LN; Matyunina LV; Walker LD; Daneker GW; McDonald JF
    Pancreas; 2014 Mar; 43(2):198-211. PubMed ID: 24518497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Personalized medicine in pancreatic cancer: prognosis and potential implications for therapy.
    Iacobuzio-Donahue CA
    J Gastrointest Surg; 2012 Sep; 16(9):1651-2. PubMed ID: 22744639
    [No Abstract]   [Full Text] [Related]  

  • 19. Improving pancreatic cancer diagnosis using circulating tumor cells: prospects for staging and single-cell analysis.
    Court CM; Ankeny JS; Hou S; Tseng HR; Tomlinson JS
    Expert Rev Mol Diagn; 2015; 15(11):1491-504. PubMed ID: 26390158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Personalizing pancreatic cancer organoids with hPSCs.
    Zhang HC; Kuo CJ
    Nat Med; 2015 Nov; 21(11):1249-51. PubMed ID: 26540385
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.